[Antitumor effect of interferon against human choriocarcinoma cell lines]. 1982

S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa

In this report, we describe the inhibitory effect of two kinds of human interferons, IFN-alpha and IFN-beta, on the growth of human choriocarcinoma cell lines in vitro and in vivo on comparing the other various cell lines derived from gynecologic malignancies. As compared to human endometrial (HEC-1B) or ovarian (HOC-21) adenocarcinoma cells which were highly resistant to the inhibitory effect of IFN-beta on the DNA synthesis at any doses up to 10,000U/ml, two human choriocarcinoma cell lines, BeWo and HCCM-5, and yolk sac tumor cell line YS-K were relatively sensitive. However, the inhibition was not dose-dependent. The growth of BeWo and HCCM-5 cells were also inhibited by either IFN-alpha or IFN-beta at concentration of 1,000U/ml and the inhibition became conspicuous when the treatment was prolonged to 4 days or more. When the hamsters transplanted with BeWo or HCCM-5 cells were treated with 10,000U IFN-beta on every day from the first till the 7th day after inoculation of cells, the tumor weights decreased to about one-half of those of non-treated controls. In contrast, the tumor weights were almost the same as non-treated controls when the animals were given with IFN-beta from the 7th day till the 13th day.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008649 Mesonephroma A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed) Mesonephromas
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D005260 Female Females
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
July 1983, Virology,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
October 2005, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
January 1987, Nihon Sanka Fujinka Gakkai zasshi,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
August 1992, American journal of obstetrics and gynecology,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
December 1990, The Journal of general virology,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
July 1992, Cancer research,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
July 1984, Nihon Sanka Fujinka Gakkai zasshi,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
January 1999, International journal of oncology,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
March 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sekiya, and T Kaiho, and S Shirotake, and H Takamizawa
August 2009, Anticancer research,
Copied contents to your clipboard!